Prevalent and Incident Tuberculosis Are Independent Risk Factors for Mortality among Patients Accessing Antiretroviral Therapy in South Africa

被引:48
|
作者
Gupta, Ankur [1 ]
Wood, Robin [2 ]
Kaplan, Richard [2 ]
Bekker, Linda-Gail [2 ]
Lawn, Stephen D. [1 ,2 ]
机构
[1] London Sch Hyg & Trop Med, Dept Clin Res, Fac Infect & Trop Dis, London WC1, England
[2] Univ Cape Town, Desmond Tutu HIV Ctr, Inst Infect Dis & Mol Med, Fac Hlth Sci, ZA-7925 Cape Town, South Africa
来源
PLOS ONE | 2013年 / 8卷 / 02期
基金
美国国家卫生研究院; 英国惠康基金;
关键词
HIV-ASSOCIATED TUBERCULOSIS; IMMUNE RECONSTITUTION DISEASE; SUB-SAHARAN AFRICA; PULMONARY TUBERCULOSIS; TREATMENT PROGRAM; INFECTED PATIENTS; EARLY OUTCOMES; RURAL UGANDA; ADULTS; DETERMINANTS;
D O I
10.1371/journal.pone.0055824
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: Patients with prevalent or incident tuberculosis (TB) in antiretroviral treatment (ART) programmes in sub-Saharan Africa have high mortality risk. However, published data are contradictory as to whether TB is a risk factor for mortality that is independent of CD4 cell counts and other patient characteristics. Methods/Findings: This observational ART cohort study was based in Cape Town, South Africa. Deaths from all causes were ascertained among patients receiving ART for up to 8 years. TB diagnoses and 4-monthly CD4 cell counts were recorded. Mortality rates were calculated and Poisson regression models were used to calculate incidence rate ratios (IRR) and identify risk factors for mortality. Of 1544 patients starting ART, 464 patients had prevalent TB at baseline and 424 developed incident TB during a median of 5.0 years follow-up. Most TB diagnoses (73.6%) were culture-confirmed. A total of 208 (13.5%) patients died during ART and mortality rates were 8.84 deaths/100 person-years during the first year of ART and decreased to 1.14 deaths/100 person-years after 5 years. In multivariate analyses adjusted for baseline and time-updated risk factors, both prevalent and incident TB were independent risk factors for mortality (IRR 1.7 [95% CI, 1.2-2.3] and 2.7 [95% CI, 1.9-3.8], respectively). Adjusted mortality risks were higher in the first 6 months of ART for those with prevalent TB at baseline (IRR 2.33; 95% CI, 1.5-3.5) and within the 6 months following diagnoses of incident TB (IRR 3.8; 95% CI, 2.6-5.7). Conclusions: Prevalent TB at baseline and incident TB during ART were strongly associated with increased mortality risk. This effect was time-dependent, suggesting that TB and mortality are likely to be causally related and that TB is not simply an epiphenomenon among highly immunocompromised patients. Strategies to rapidly diagnose, treat and prevent TB prior to and during ART urgently need to be implemented.
引用
收藏
页数:8
相关论文
共 50 条
  • [21] The extraordinary hope of Antiretroviral therapy in South Africa (even for patients with tuberculosis or Kaposi sarcoma!)
    Flanigan, TP
    Campbell, T
    Harwell, J
    Kumarasamy, N
    JOURNAL OF INFECTIOUS DISEASES, 2005, 191 (03): : 321 - 323
  • [22] Cardiometabolic risk factors among HIV patients on antiretroviral therapy
    James N Kiage
    Douglas C Heimburger
    Christopher K Nyirenda
    Melissa F Wellons
    Shashwatee Bagchi
    Benjamin H Chi
    John R Koethe
    Donna K Arnett
    Edmond K Kabagambe
    Lipids in Health and Disease, 12
  • [23] Tuberculosis among adults starting antiretroviral therapy in South Africa: the need for routine case finding
    Hanifa, Y.
    Fielding, K. L.
    Charalambous, S.
    Variava, E.
    Luke, B.
    Churchyard, G. J.
    Grant, A. D.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2012, 16 (09) : 1252 - 1259
  • [24] Cardiometabolic risk factors among HIV patients on antiretroviral therapy
    Kiage, James N.
    Heimburger, Douglas C.
    Nyirenda, Christopher K.
    Wellons, Melissa F.
    Bagchi, Shashwatee
    Chi, Benjamin H.
    Koethe, John R.
    Arnett, Donna K.
    Kabagambe, Edmond K.
    LIPIDS IN HEALTH AND DISEASE, 2013, 12
  • [25] Early mortality among adults accessing a community-based antiretroviral service in South Africa: implications for programme design
    Lawn, SD
    Myer, L
    Orrell, C
    Bekker, LG
    Wood, R
    AIDS, 2005, 19 (18) : 2141 - 2148
  • [26] Drug-Resistant Tuberculosis among HIV-Infected Patients Starting Antiretroviral Therapy in Durban, South Africa
    Hom, Jeffrey K.
    Wang, Bingxia
    Chetty, Senica
    Giddy, Janet
    Mazibuko, Matilda
    Allen, Jenny
    Walensky, Rochelle P.
    Losina, Elena
    Freedberg, Kenneth A.
    Bassett, Ingrid V.
    PLOS ONE, 2012, 7 (08):
  • [27] Assessing the impact of prevalent tuberculosis on mortality among antiretroviral treatment initiators: accurate tuberculosis diagnosis is essential
    Lawn, Stephen D.
    Gupta, Ankur
    Wood, Robin
    AIDS, 2012, 26 (13) : 1730 - 1731
  • [28] Reply to Ouattara et al.:: past history of tuberculosis is not a risk factor for incident tuberculosis during antiretroviral treatment in South Africa
    Lawn, Stephen D.
    Myer, Landon
    Badri, Motasim
    Bekker, Linda-Gail
    Wood, Robin
    AIDS, 2007, 21 (03) : 388 - 389
  • [29] Screening for Cryptococcal Antigenemia in Patients Accessing an Antiretroviral Treatment Program in South Africa
    Jarvis, Joseph N.
    Lawn, Stephen D.
    Vogt, Monica
    Bangani, Nonzwakazi
    Wood, Robin
    Harrison, Thomas S.
    CLINICAL INFECTIOUS DISEASES, 2009, 48 (07) : 856 - 862
  • [30] IMPACT OF TUBERCULOSIS ON MORTALITY AMONG HIV-INFECTED PATIENTS RECEIVING ANTIRETROVIRAL THERAPY
    Chu, R.
    Mills, E.
    Beyene, J.
    Bakanda, C.
    Nachega, J.
    Thabane, L.
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2011, 173 : S73 - S73